Links to Data sources
| Sr. No | Display Name | Type | Country | Last Updated |
|---|---|---|---|---|
| 1 | Calliope | Data Source | France | 16/05/2013 |
Links to Studies
| Status | Official Title | Lead Investigator | Last Updated |
|---|---|---|---|
| Finalised | Assessment of the safety of LABAs in asthma in routine care by combining healthcare databases and direct patient follow-up | Dr Eric VAN GANSE | 29/07/2016 |
| Ongoing | A 5-year multi-center, observational post-authorization safety study to document the drug utilisation of Wakix® in the treatment of narcolepsy with or without cataplexy and to collect information on its long termthe safety of Wakix® when used in routine medical practice | Dr Stéphane SCHÜCK | 10/08/2020 |
| Ongoing | Observatory of TTR-related amyloidosis and of patients treated with Vyndaqel(r) | Dr Olivier DEMARCQ | 16/12/2019 |
| Planned | Real-life efficacy and safety of patients treated with ixazomib in combination with lenalidomide and dexamethasone, for relapsed and/or refractory multiple myeloma: a prospective, non-interventional, real-life study | Dr Stéphane SCHÜCK | 10/11/2017 |
© 1995-2020 European Medicines Agency | Contact Us | Privacy Policy
| Admin Login | Disclaimer
As of 1.2.2020, the UK is no longer an EU Member State. However, EU law still applies to the UK during the transition period.
Version: 4.4.1.1